Overview

Sebia is an in vitro diagnostics company headquartered in Lisses, France, founded in 1967. It employs an estimated 1,000 to 5,000 people and has an estimated revenue band of $100 to 250 million. The company is privately held and serves laboratories focused on clinical protein analysis and diagnosis of chronic, metabolic, and immune-related conditions. Its capillary electrophoresis systems are a core offering, and in November 2025 it announced an exclusive global strategic partnership with ABIONYX Pharma to develop sepsis diagnosis.

At a glance

What Sebia makes

Sebia holds ISO 9001, ISO 13485, ISO 14001, and ISO 45001 certifications and manufactures capillary electrophoresis systems for protein analysis, including the CAPILLARYS 3 Family and the Alegria 2 system.

Certifications

Sebia is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

• ISO 13485 — optimizely.com

• ISO 14001 — optimizely.com

• ISO 45001 — optimizely.com

• ISO 9001 — wikigiga.net

Latest developments

• 2026-11-02 — SEBIA HISPANIA, S.A. public tenders won: 24 contract awards (arcadiumdata.io)

• 2026-04-10 — Fornitura di sistemi diagnostici, reattivi e materiale di consumo per il laboratorio di elettroforesi delle proteine — SEBIA ITALIA S.R.L. · Adjudera (adjudera.com)

• 2025-11-20 — ABIONYX Pharma and SEBIA Announce an Exclusive Global Strategic Partnership to Transform Sepsis Diagnosis (businesswire.com)

• 2025-10-16 — Sebia est heureux d’annoncer l’entrée en négociations exclusives en vue d’accueillir Warburg Pincus à son capital | Sebia | FR (sebia.com)

• 2025-09-24 — Fastpartner hyr ut till Sebia Sweden och Grifols Nordic i Centrala Frösunda - Fastpartner (cision.com)

Company details

Sebia is privately held, with an estimated employee base of 1,000 to 5,000 and an estimated revenue band of $100 to 250 million; the revenue figure is an estimate. Sebia was founded in 1967, has an estimated 1,000-5,000 employees, and is headquartered in Lisses, Ile-de-France. On the LightSource stability read it is rated "Established & active": 59 years in operation (founded 1967). Holds ISO 13485, ISO 14001, ISO 45001, ISO 9001 certification(s) per public sources.

Frequently asked questions

What does Sebia make?

Sebia is an in vitro diagnostics company headquartered in Lisses, France, founded in 1967. It employs an estimated 1,000 to 5,000 people and has an estimated revenue band of $100 to 250 million. The company is privately held and serves laboratories focused on clinical protein analysis and diagnosis of chronic, metabolic, and immune-related conditions. Its capillary electrophoresis systems are a core offering, and in November 2025 it announced an exclusive global strategic partnership with ABIONYX Pharma to develop sepsis diagnosis.

Where is Sebia headquartered?

Sebia is headquartered in Lisses, Ile-de-France (10 Rue Leonard de Vinci, Lisses, Ile-de-France, 91090).

When was Sebia founded?

Sebia was founded in 1967.

How big is Sebia?

Sebia has an estimated 1,000-5,000 employees, with revenue in the $100-250M range (estimated).

What certifications does Sebia hold?

Sebia lists ISO 13485 · ISO 14001 · ISO 45001 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.

Related suppliers

Explore other suppliers in the LightSource directory:

• 10xEngineers

• 1X

• 365 Retail Markets

• 3Com

• 3PAR

Last verified Nov 2026. Is this your company? Request a correction.